Age Related Multiple Sclerosis Severity Score: Disability ranked by age.

Ali Manouchehrinia, Helga Westerlind, Elaine Kingwell, Feng Zhu, Robert Carruthers, Ryan Ramanujam, Maria Ban, Anna Glaser, Stephen Sawcer, Helen Tremlett, Jan Hillert
{"title":"Age Related Multiple Sclerosis Severity Score: Disability ranked by age.","authors":"Ali Manouchehrinia, Helga Westerlind, Elaine Kingwell, Feng Zhu, Robert Carruthers, Ryan Ramanujam, Maria Ban, Anna Glaser, Stephen Sawcer, Helen Tremlett, Jan Hillert","doi":"10.1177/1352458517690618","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Multiple Sclerosis Severity Score (MSSS) is obtained by normalising the Expanded Disability Status Scale (EDSS) score for disease duration and has been a valuable tool in cross-sectional studies.</p><p><strong>Objective: </strong>To assess whether use of age rather than the inherently ambiguous disease duration was a feasible approach.</p><p><strong>Method: </strong>We pooled disability data from three population-based cohorts and developed an Age Related Multiple Sclerosis Severity (ARMSS) score by ranking EDSS scores based on the patient's age at the time of assessment. We established the power to detect a difference between groups afforded by the ARMSS score and assessed its relative consistency over time.</p><p><strong>Results: </strong>The study population included 26058 patients from Sweden ( n = 11846), Canada ( n = 6179) and the United Kingdom ( n = 8033). There was a moderate correlation between EDSS and disease duration ( r = 0.46, 95% confidence interval (CI): 0.45-0.47) and between EDSS and age ( r = 0.44, 95% CI: 0.43-0.45). The ARMSS scores showed comparable power to detect disability differences between groups to the updated and original MSSS.</p><p><strong>Conclusion: </strong>Since age is typically unbiased and readily obtained, and the ARMSS and MSSS were comparable, the ARMSS may provide a more versatile tool and could minimise study biases and loss of statistical power caused by inaccurate or missing onset dates.</p>","PeriodicalId":17203,"journal":{"name":"Journal of The American Dietetic Association","volume":"108 1","pages":"1938-1946"},"PeriodicalIF":0.0000,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1352458517690618","citationCount":"91","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of The American Dietetic Association","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/1352458517690618","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/2/3 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 91

Abstract

Background: The Multiple Sclerosis Severity Score (MSSS) is obtained by normalising the Expanded Disability Status Scale (EDSS) score for disease duration and has been a valuable tool in cross-sectional studies.

Objective: To assess whether use of age rather than the inherently ambiguous disease duration was a feasible approach.

Method: We pooled disability data from three population-based cohorts and developed an Age Related Multiple Sclerosis Severity (ARMSS) score by ranking EDSS scores based on the patient's age at the time of assessment. We established the power to detect a difference between groups afforded by the ARMSS score and assessed its relative consistency over time.

Results: The study population included 26058 patients from Sweden ( n = 11846), Canada ( n = 6179) and the United Kingdom ( n = 8033). There was a moderate correlation between EDSS and disease duration ( r = 0.46, 95% confidence interval (CI): 0.45-0.47) and between EDSS and age ( r = 0.44, 95% CI: 0.43-0.45). The ARMSS scores showed comparable power to detect disability differences between groups to the updated and original MSSS.

Conclusion: Since age is typically unbiased and readily obtained, and the ARMSS and MSSS were comparable, the ARMSS may provide a more versatile tool and could minimise study biases and loss of statistical power caused by inaccurate or missing onset dates.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
年龄相关性多发性硬化严重程度评分:残疾按年龄排序。
背景:多发性硬化症严重程度评分(MSSS)是通过对疾病持续时间的扩展残疾状态量表(EDSS)评分进行标准化得到的,在横断面研究中是一个有价值的工具。目的:评估使用年龄而不是固有的模糊疾病持续时间是否是可行的方法。方法:我们汇集了来自三个基于人群的队列的残疾数据,并根据评估时患者的年龄对EDSS评分进行排序,制定了年龄相关多发性硬化症严重程度(ARMSS)评分。我们建立了由ARMSS评分提供的检测组间差异的能力,并评估了其随时间的相对一致性。结果:研究人群包括26058例患者,分别来自瑞典(n = 11846)、加拿大(n = 6179)和英国(n = 8033)。EDSS与病程呈正相关(r = 0.46, 95%可信区间(CI): 0.45-0.47),与年龄呈正相关(r = 0.44, 95% CI: 0.43-0.45)。与更新的和原始的mss相比,ARMSS评分在检测组间残疾差异方面显示出相当的能力。结论:由于年龄通常是无偏倚且易于获得的,而且ARMSS和MSSS具有可比性,因此ARMSS可能提供了一个更通用的工具,可以最大限度地减少研究偏差和因发病日期不准确或缺失而导致的统计能力损失。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
>12 weeks
期刊最新文献
Analyzing bivariate cross-trait genetic architecture in GWAS summary statistics with the BIGA cloud computing platform. Early adversity and emotional awareness: A partial confirmation and extension of their relationship. Comparison of Outcomes of Early Versus Late Tracheostomy in the Treatment of Mechanically Ventilated Critically ill Patients. A Case Report of Chondromyxoid Fibroma of the Nasal Cavity. Effects of COVID-19 Infection and Vaccines on Patients with Epilepsy: Real-Life Experiences.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1